STAGE IIIC RECTAL CANCER AJCC V8
Clinical trials for STAGE IIIC RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIC RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink rectal tumors before surgery
Disease control CompletedThis early-stage study tests the safety of combining the chemotherapy drug TAS-102 with radiation therapy for people with stage II or III rectal cancer that hasn't been treated yet. The goal is to find the safest dose of TAS-102 to use with radiation before surgery to remove the …
Matched conditions: STAGE IIIC RECTAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New cocktail of drugs shows promise for tough colorectal cancer
Disease control CompletedThis phase 1 trial tested a combination of regorafenib (a targeted therapy) plus two immunotherapy drugs (nivolumab and ipilimumab) in 39 patients with advanced colorectal cancer that had spread and stopped responding to chemotherapy. The goal was to find the safest dose and chec…
Matched conditions: STAGE IIIC RECTAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC